Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Generic Injectables Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The global generic injectables market reached a value of US$ 40.1 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 65.4 Billion by 2027, exhibiting at a CAGR of 8.6% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

A generic injectable is a drug formulated with the same active pharmaceutical ingredient as its branded counterpart in strength, dosage form, safety, performance, quality, intended use, side effects, and route of administration. It is as safe and effective as the innovator drug and is consequently used for administering the medication rapidly into the body. It facilitates the easy absorption of medicines in liquid form, which helps reduce the frequency of dosage administration without affecting the efficacy of the treatment. Besides this, it is cost-effective and does not require investment in testing, promotional activities, and research and development (R&D) compared to its branded counterparts. As a result, generic injectables are extensively utilized in treating cancer, diabetes, osteoporosis, osteoarthritis, rheumatoid arthritis, and respiratory, neurological, and cardiovascular disorders.

 

 
 

www.imarcgroup.com

Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

Generic Injectables Market Trends:

The growing global geriatric population, which is more susceptible to several chronic medical ailments, such as diabetes, cancer, and cardiovascular diseases, represents one of the key factors driving the demand for generic injectables worldwide. In addition, the rising occurrence of lifestyle disorders due to hectic schedules, changing dietary patterns, and sedentary lifestyles of individuals are positively influencing the market. Apart from this, initiatives undertaken by governing authorities of numerous countries to support key manufacturers and sellers are offering lucrative growth opportunities to manufacturers. This, along with the widespread adoption of advanced technologies in the manufacturing process of generic injectables, is propelling the market growth. Furthermore, the expansion of offline pharmacies, along with the easy availability of generic injectables via online pharmacies, is offering a favorable market outlook. The emerging trend of online shopping offers consumers a wide range of products, free doorstep delivery, exciting deals and discounts, and secured payment methods is anticipated to drive the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global generic injectables market, along with forecasts at the global and regional level from 2022-2027. Our report has categorized the market based on therapeutic area, container, and distribution channel.

Breakup by Therapeutic Area:

 

 
 

www.imarcgroup.com

Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

  • Oncology
  • Anaesthesia
  • Anti-infectives
  • Parenteral Nutrition
  • Cardiovascular
     

The oncology segment currently dominates the market due to the increasing number of cancer patients.

Breakup by Container:

On the basis of the container, the market has been segmented into vials, ampoules, premix, and prefilled syringes.

Breakup by Distribution Channel:

  • Hospitals
  • Retail Pharmacy 
     

Hospitals hold the largest market share due to the increasing cases of chronic medical disorders and the growing expansion of hospitals across the globe.

Regional Insights:

 

 
 

www.imarcgroup.com

To get more information on the regional analysis of this market, Request Sample

  • Europe
  • North America
  • Asia 
  • Latin America
  • Middle East and Africa
     

North America enjoys the leading position in the market due to the existence of various leading manufacturers in the country.

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being

  • Hospira (Pfizer)
  • Fresenius Kabi
  • Hikma
  • Sandoz (Novartis)
  • Sagent
  • Sanofi
  • Baxter
     

This report provides a deep insight into the global generic injectables industry covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. The report also provides a comprehensive analysis for setting up a generic injectables manufacturing plant. The study analyses the processing and manufacturing requirements, project cost, project funding, project economics, expected returns on investment, profit margins, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the global generic injectables industry in any manner.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Billion
Segment Coverage Therapeutic Area, Container, Distribution Channel, Region
Region Covered  Asia, Europe, North America, Latin America, Middle East and Africa
Companies Covered Hospira (Pfizer), Fresenius Kabi, Hikma, Sandoz (Novartis), Sagent, Sanofi and Baxter
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

1   Preface
2   Scope and Methodology

    2.1 Objectives of the Study
    2.2 Stakeholders
    2.3 Data Sources
        2.3.1 Primary Sources
        2.3.2 Secondary Sources
    2.4 Market Estimation
        2.4.1 Bottom-Up Approach
        2.4.2 Top-Down Approach
    2.5 Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1 Overview    
    4.2 Key Industry Trends
5   Global Generic Drug Market
    5.1 Market Overview
    5.2 Market Performance
    5.3 Market Breakup by Region
    5.4 Market Forecast
    5.5 Major Players
6   Global Generic Drug Delivery Market
    6.1 Oral
    6.2 Injectables   
    6.3 Dermal/Topical
    6.4 Inhalers
7   Global Generic Injectables Market
    7.1 Market Overview
    7.2 Market Performance
    7.3 Impact of COVID-19
    7.4 Market Breakup by Region
    7.5 Market Breakup by Therapeutic Area
    7.6 Market Breakup by Container
    7.7 Market Breakup by Distribution Channel
    7.8 Market Forecast
    7.9 SWOT Analysis
        7.9.1 Overview
        7.9.2 Strengths
        7.9.3 Weaknesses
        7.9.4 Opportunities
        7.9.5 Threats
    7.10 Value Chain Analysis
    7.11 Porter’s Five Forces Analysis
        7.11.1 Overview
        7.11.2 Bargaining Power of Buyers
        7.11.3 Bargaining Power of Suppliers
        7.11.4 Degree of Competition
        7.11.5 Threat of New Entrants
        7.11.6 Threat of Substitutes
     7.12 Key Market Drivers and Success Factors
8   Global Generic Injectables Market: Performance of Key Regions
    8.1 North America
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2 Europe
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3 Asia
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4 Latin America
        8.4.1 Market Trends
        8.4.2 Market Forecast
    8.5 Middle East and Africa
        8.5.1 Market Trends
        8.5.2 Market Forecast
9   Market by Therapeutic Area
    9.1 Oncology
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2 Anaesthesia
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3 Anti-infectives
        9.3.1 Market Trends
        9.3.2 Market Forecast
    9.4 Parenteral Nutrition
        9.4.1 Market Trends
        9.4.2 Market Forecast
    9.5 Cardiovascular
        9.5.1 Market Trends
        9.5.2 Market Forecast
10   Market by Container
     10.1 Vials
        10.1.1 Market Trends
        10.1.2 Market Forecast
    10.2 Ampoules
        10.2.1 Market Trends
        10.2.2 Market Forecast
    10.3 Premix
        10.3.1 Market Trends
        10.3.2 Market Forecast
    10.4 Prefilled Syringes
        10.4.1 Market Trends
        10.4.2 Market Forecast
11  Market by Distribution Channel
    11.1 Hospitals
        11.1.1 Market Trends
        11.1.2 Market Forecast
    11.2 Retail Pharmacy 
        11.2.1 Market Trends
        11.2.2 Market Forecast
12  Global Generic Injectables Market: Competitive Landscape
    12.1 Market Structure
    12.2 Market Breakup by Key Players    
13  Generic Injectables Manufacturing Process
    13.1 Product Overview
    13.2 Detailed Process Flow (Injectables)
    13.3 Various Types of Unit Operations Involved
    13.4 Mass Balance and Raw Material Requirements
14  Project Details, Requirements and Costs Involved
    14.1 Land Requirements and Expenditures
    14.2 Construction Requirements and Expenditures
    14.3 Plant Machinery
    14.4 Machinery Pictures
    14.5 Raw Material Requirements and Expenditures
    14.6 Packaging Requirements and Expenditures
    14.7 Transportation Requirements and Expenditures
    14.8 Utility Requirements and Expenditures
    14.9 Manpower Requirements and Expenditures
    14.10 Other Capital Investments
15  Loans and Financial Assistance
16  Project Economics

    16.1 Capital Cost of the Project
    16.2 Techno-Economic Parameters
    16.3 Product Pricing and Margins Across Various Levels of the Supply Chain
    16.4 Taxation and Depreciation
    16.5 Income Projections
    16.6 Expenditure Projections
    16.7 Financial Analysis
    16.8 Profit Analysis
17  Key Player Profiles
     17.1 Hospira (Pfizer)
         17.1.1 Company Overview
         17.1.2 Product Portfolio
         17.1.3 Financials
         17.1.4 SWOT Analysis
     17.2 Fresenius Kabi
         17.2.1 Company Overview
         17.2.2 Product Portfolio
         17.2.3 Financials
         17.2.4 SWOT Analysis
     17.3 Hikma
         17.3.1 Company Overview
         17.3.2 Product Portfolio
         17.3.3 Financials
         17.3.4 SWOT Analysis
     17.4 Sandoz (Novartis)
         17.4.1 Company Overview
         17.4.2 Product Portfolio
         17.4.3 Financials
         17.4.4 SWOT Analysis
     17.5 Sagent
         17.5.1 Company Overview
         17.5.2 Product Portfolio
         17.5.3 Financials
         17.5.4 SWOT Analysis
     17.6 Sanofi
         17.6.1 Company Overview
         17.6.2 Product Portfolio
         17.6.3 Financials
         17.6.4 SWOT Analysis
     17.7 Baxter
         17.7.1 Company Overview
         17.7.2 Product Portfolio
         17.7.3 Financials
         17.7.4 SWOT Analysis


List of Figures

Figure 1: Global: Generic Drug Market: Value Trends (in Billion US$), 2016 - 2021
Figure 2: Global: Generic Drug Market: Breakup by Region (in %), 2021
Figure 3: Global: Generic Drug Market Forecast: Value Trends (in Billion US$), 2022-2027
Figure 4: Global: Generic Drug Delivery Market: Oral (in Million US$), 2016, 2021 & 2027
Figure 5: Global: Generic Drug Delivery Market: Injectables (in Million US$), 2016, 2021 & 2027
Figure 6: Global: Generic Drug Delivery Market: Dermal/Topical (in Million US$), 2016, 2021 & 2027
Figure 7: Global: Generic Drug Delivery Market: Inhalers (in Million US$), 2016, 2021 & 2027
Figure 8: Global: Generic Injectables Market: Value Trends (in Billion US$), 2016 - 2021
Figure 9: Global: Generic Injectables Market: Breakup by Region (in %), 2021
Figure 10: Global: Generic Injectables Market: Breakup by Therapeutic Area (in %), 2021
Figure 11: Global: Generic Injectables Market: Breakup by Container (in %), 2021
Figure 12: Global: Generic Injectables Market: Breakup by Distribution Channel (in %), 2021
Figure 13: Global: Generic Injectables Market Forecast: Value Trends (in Billion US$), 2022-2027
Figure 14: Global: Generic Injectables Industry: SWOT Analysis
Figure 15: Global: Generic Injectables Industry: Value Chain Analysis
Figure 16: Global: Generic Injectables Industry: Porter’s Five Forces Analysis
Figure 17: North America: Generic Injectables Market (in Million US$), 2016 & 2021
Figure 18: North America: Generic Injectables Market Forecast (in Million US$), 2022-2027
Figure 19: Europe: Generic Injectables Market (in Million US$), 2016 & 2021
Figure 20: Europe: Generic Injectables Market Forecast (in Million US$), 2022-2027
Figure 21: Asia: Generic Injectables Market (in Million US$), 2016 & 2021
Figure 22: Asia: Generic Injectables Market Forecast (in Million US$), 2022-2027
Figure 23: Latin America: Generic Injectables Market (in Million US$), 2016 & 2021
Figure 24: Latin America: Generic Injectables Market Forecast (in Million US$), 2022-2027
Figure 25: Middle East and Africa: Generic Injectables Market (in Million US$), 2016 & 2021
Figure 26: Middle East and Africa: Generic Injectables Market Forecast (in Million US$), 2022-2027
Figure 27: Global: Generic Injectables (Oncology) Market: Value Trends (in Million US$), 2016 & 2021
Figure 28: Global: Generic Injectables (Oncology) Market Forecast: Value Trends (in Million US$), 2022-2027
Figure 29: Global: Generic Injectables (Anaesthesia) Market: Value Trends (in Million US$), 2016 & 2021
Figure 30: Global: Generic Injectables (Anaesthesia) Market Forecast: Value Trends (in Million US$), 2022-2027
Figure 31: Global: Generic Injectables (Anti-infectives) Market: Value Trends (in Million US$), 2016 & 2021
Figure 32: Global: Generic Injectables (Anti-infectives) Market Forecast: Value Trends (in Million US$), 2022-2027
Figure 33: Global: Generic Injectables (Parenteral Nutrition) Market: Value Trends (in Million US$), 2016 & 2021
Figure 34: Global: Generic Injectables (Parenteral Nutrition) Market Forecast: Value Trends (in Million US$), 2022-2027
Figure 35: Global: Generic Injectables (Cardiovascular) Market: Value Trends (in Million US$), 2016 & 2021
Figure 36: Global: Generic Injectables (Cardiovascular) Market Forecast: Value Trends (in Million US$), 2022-2027
Figure 37: Global: Generic Injectables (Vials) Market: Value Trends (in Million US$), 2016 & 2021
Figure 38: Global: Generic Injectables (Vials) Market Forecast: Value Trends (in Million US$), 2022-2027
Figure 39: Global: Generic Injectables (Ampoules) Market: Value Trends (in Million US$), 2016 & 2021
Figure 40: Global: Generic Injectables (Ampoules) Market Forecast: Value Trends (in Million US$), 2022-2027
Figure 41: Global: Generic Injectables (Premix) Market: Value Trends (in Million US$), 2016 & 2021
Figure 42: Global: Generic Injectables (Premix) Market Forecast: Value Trends (in Million US$), 2022-2027
Figure 43: Global: Generic Injectables (Prefilled Syringes) Market: Value Trends (in Million US$), 2016 & 2021
Figure 44: Global: Generic Injectables (Prefilled Syringes) Market Forecast: Value Trends (in Million US$), 2022-2027
Figure 45: Global: Generic Injectables Market: Sales through Hospitals (in Million US$), 2016 & 2021
Figure 46: Global: Generic Injectables Market Forecast: Sales through Hospitals (in Million US$), 2022-2027
Figure 47: Global: Generic Injectables Market: Sales through Retail Pharmacy (in Million US$), 2016 & 2021
Figure 48: Global: Generic Injectables Market Forecast: Sales through Retail Pharmacy (in Million US$), 2022-2027
Figure 49: Generic Injectables Manufacturing Process: Conversion Rate of Feedstocks
Figure 50: Generic Injectables Manufacturing: Detailed Process Flow
Figure 51: Generic Injectables Manufacturing: Production Cost Breakup (in %)
Figure 52: Generic Injectables Industry: Profit Margins at Various Levels of the Supply Chain
Figure 53: Generic Injectables Manufacturing Plant: Proposed Plant Layout
Figure 54: Generic Injectables Manufacturing Plant: Breakup of Capital Costs (in %)


List of Tables

Table 1: Global: Generic Drug Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Generic Drug Market Forecast: Breakup by Region, 2022-2027
Table 3: Global: Generic Drug Market: Revenues of Key Players (in Million US$), 2019
Table 4: Global: Generic Injectables Market: Key Industry Highlights, 2021 and 2027
Table 5: Global: Generic Injectables Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Generic Injectables Market Forecast: Breakup by Therapeutic Area (in Million US$), 2022-2027
Table 7: Global: Generic Injectables Market Forecast: Breakup by Container (in Million US$), 2022-2027
Table 8: Global: Generic Injectables Market Forecast: Breakup by Distribution Channel (in Million US$), 2022-2027
Table 9: Generic Injectables Manufacturing Plant: Costs Related to Land and Site Development (in US$)
Table 10: Generic Injectables Manufacturing Plant: Costs Related to Civil Works (in US$)
Table 11: Generic Injectables Manufacturing Plant: Costs Related to Machinery Unit (in US$)
Table 12: Generic Injectables Manufacturing Plant: Raw Material Requirements (Kg/Day) and Expenditures (US$/Kg)
Table 13: Generic Injectables Manufacturing Plant: Costs Related to Salaries and Wages (in US$)
Table 14: Generic Injectables Manufacturing Plant: Costs Related to Other Capital Investments (in US$)
Table 15: Details of Financial Assistance Offered by Financial Institutions
Table 16: Generic Injectables Manufacturing Plant: Capital Costs (in US$)
Table 17: Generic Injectables Manufacturing Plant: Techno-Economic Parameters (in US$)
Table 18: Generic Injectables Manufacturing Plant: Taxation and Depreciation (in US$)
Table 19: Generic Injectables Manufacturing Plant: Income Projections (in US$)
Table 20: Generic Injectables Manufacturing Plant: Expenditure Projections (in US$)
Table 21: Generic Injectables Manufacturing Plant: Cash Flow Analysis Without Considering the Income Tax Liability (in US$)
Table 22: Generic Injectables Manufacturing Plant: Cash Flow Analysis on Considering the Income Tax Liability (in US$)
Table 23: Generic Injectables Manufacturing Plant: Profit and Loss Account (in US$)


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Key Questions Answered in This Report

The global generic injectables market was valued at US$ 40.1 Billion in 2021.

We expect the global generic injectables market to exhibit a CAGR of 8.6% during 2022-2027.

The sudden outbreak of the COVID-19 pandemic has led to the easy availability of generic injectables via online pharmacies with free doorstep delivery, to combat the risk of the coronavirus infection.

The rising utilization of generic injectables in treating various cardiovascular disorders without affecting the efficacy of the treatment is primarily driving the global generic injectables market.

Based on the therapeutic area, the global generic injectables market can be segmented into oncology, anesthesia, anti-infectives, parenteral nutrition, and cardiovascular. Among these, oncology segment holds the majority of the total market share.

Based on the distribution channel, the global generic injectables market has been segregated into hospitals and retail pharmacy. Currently, hospitals hold the largest market share.
 

On a regional level, the market can be classified into Europe, North America, Asia, Latin America, and Middle East and Africa, where North America currently dominates the global market. 
 

Some of the major players in the global generic injectables market include Hospira, Inc. (Pfizer Inc.), Fresenius Kabi AG, Hikma Pharmaceuticals PLC, Sandoz (Novartis), Sagent M&C, LLC, Sanofi S.A., Baxter International, Inc., etc.

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links